annb0t
Top 20
Boston Scientific Corporation BSX recently presented favorable six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System â the first modular cardiac rhythm management system that consists of the EMBLEM Subcutaneous Implantable Defibrillator or S-ICD System and the EMPOWER Leadless Pacemaker. The findings were concurrently published in the New England Journal of Medicine and presented at the Heart Rhythm Society's annual meeting, Heart Rhythm 2024.
The recent ...
>>> Read more: Boston Scientific (BSX) mCRM System Study Outcome Favorable
The recent ...
>>> Read more: Boston Scientific (BSX) mCRM System Study Outcome Favorable
